CONATUS PHARMACEUTICALS INC - COM (CNAT)

CUSIP: 20600T108

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
9,980,329
Share change
+4,558,458
Total reported value
$57,482,688
Put/Call ratio
71%
Price per share
$5.76
Number of holders
70
Value change
+$26,271,514
Number of buys
54
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 20600T108?
CUSIP 20600T108 identifies CNAT - CONATUS PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CONATUS PHARMACEUTICALS INC - COM (CNAT) as of Q2 2017

As of 30 Jun 2017, CONATUS PHARMACEUTICALS INC - COM (CNAT) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,980,329 shares. The largest 10 holders included BlackRock Inc., MPM ASSET MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BOGLE INVESTMENT MANAGEMENT L P /DE/, AXA, STATE STREET CORP, NORTHERN TRUST CORP, and Numeric Investors LLC. This page lists 70 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.